Gummy Market Size & Share 2026-2035

Gummy Market Size

The gummy market was valued at USD 39.2 billion in 2025, is projected to reach USD 43.1 billion in 2026, and is expected to expand at a CAGR of 8.7% from 2026 to 2035, reaching USD 91.2 billion by 2035.

The gummy market combines confectionery, dietary supplement, pharmaceutical, functional food, and pet formats, creating a demand base that is broader than either conventional candy or supplements alone. Its revenue outlook is increasingly shaped by active-ingredient intensity, clean-label reformulation, and dosage-form convenience, which support premium product mixes alongside continued mainstream confectionery consumption.

Gummy Market Trends, Growth Drivers & GMI Forecast Outlook

Gummy demand is being expanded by consumer preference for easier-to-consume supplements and digitally accessible wellness products. At the same time, price pressure, ingredient dependence, and a more demanding compliance environment favor manufacturers able to pair differentiated formulations with resilient sourcing and credible product stewardship.

Key Drivers

Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.

Supplement use provides a durable base for format substitution: 75% of Americans report using dietary supplements, supporting a large addressable population for products that improve routine adherence and sensory acceptance ^{[2]Council for Responsible Nutrition (CRN), survey conducted by Ipsos. “CRN Survey Shows Consistent Supplement Usage with Increase of Specialty Product Use Over Time.” crnusa.org}. Gummy producers that protect active-ingredient stability, manage taste masking, and communicate dosage clearly are better positioned to translate convenience into repeat purchasing rather than one-time trial.

Digital distribution changes the economics of discovery and replenishment. Subscription models can improve purchase continuity for daily-use vitamin, sleep, beauty, and wellness formulations, while marketplaces enable niche brands to reach consumers outside traditional pharmacy and grocery shelf allocation. The advantage is strongest where online channels can compensate for fragmented specialist retail infrastructure.

Plant-based reformulation is also changing the product-development agenda. Pectin and starch systems can widen access among consumers seeking vegan, halal, kosher, reduced-sugar, or clean-label products, but they require manufacturers to manage different texture, processing, stability, and sourcing constraints. The resulting technical barrier creates room for differentiated functional SKUs rather than simple replication of legacy gelatin recipes.

Key Restraints

Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.

Private-label competition is particularly consequential in standard multivitamin and basic wellness formats, where ingredient panels can appear comparable at first glance. Branded suppliers need a visible reason for consumers to pay more, whether through clinically credible positioning, differentiated active combinations, trusted quality systems, or superior sensory performance. Without that differentiation, rising promotional activity can erode both pricing power and retailer leverage.

Gelatin dependence creates exposure beyond ingredient procurement. It can limit product eligibility in dietary, religious, and lifestyle segments while adding traceability requirements in regulated applications. A diversified formulation portfolio can therefore serve both as a supply-risk response and as a route to address otherwise excluded consumer groups.

Gummy-specific labeling and packaging expectations also make execution more complex for entrants. Responsible serving communication, child-deterrence, substantiation of health-related claims, and documentation for novel ingredients require earlier regulatory involvement in product development. Established suppliers with quality, regulatory, and formulation capabilities are more likely to convert this complexity into a competitive barrier.

Gummy Market Segment Analysis

By Application

The gummy market application mix demonstrates how one dosage form serves distinct purchase occasions, from everyday confectionery to higher-value wellness and therapeutic use.

Confectionery

Confectionery generated USD 18.4 billion in 2025 and is expected to reach USD 38.3 billion by 2035. The segment remains the commercial anchor for gummy manufacturing, retail visibility, and broad consumer familiarity. Its growth opportunity centers on texture, flavor, sugar reduction, and premium sensory experiences rather than on the health-positioning mechanisms that drive supplement and pharmaceutical formats.

Supplement / Nutraceutical

Supplement and nutraceutical gummies generated USD 15.0 billion in 2025 and are projected to reach USD 33.8 billion by 2035. This application is a focal point for consumer-health brands and digital-native entrants because it combines daily-use frequency with a wide field of condition-specific claims. Brand trust, ingredient transparency, taste performance, and replenishment convenience are decisive for retaining consumers once the initial format trial has occurred.

Pharmaceutical

Pharmaceutical gummies are projected to reach USD 8.2 billion by 2035 and expand at an 11.8% CAGR (2026-2035). Growth reflects demand for dosage forms that can improve patient acceptance, particularly in OTC and pediatric settings. The application carries higher requirements for ingredient control, manufacturing discipline, and regulatory documentation, creating a more defensible competitive position than mainstream confectionery or basic supplement products.

Functional Food

Functional food gummies generated USD 2.2 billion in 2025 and are forecast to expand at a 13.6% CAGR (2026-2035). Functional-food demand sits at the intersection of snacking and wellness, creating room for products positioned around energy, fiber, botanical ingredients, or fortified nutrition. Success depends on delivering a credible benefit without compromising the sensory qualities consumers expect from a food-like format.

Pet

Pet gummies are projected to reach USD 2.7 billion by 2035 and grow at an 11.7% CAGR (2026-2035). The segment benefits from the extension of human wellness purchasing habits into companion-animal care. Products focused on joint, digestive, dental, and immunity support can gain traction when they simplify administration for pet owners and align with veterinary and specialty-retail purchasing behavior.

By Product Type

The gummy market product-type structure is shifting toward supplement categories in which active ingredients, formulation stability, and targeted consumer occasions matter more than simple confectionery scale.

Vitamins

Vitamin gummies generated USD 5.8 billion in 2025 and are expected to reach USD 11.5 billion by 2035. Multivitamins and single-vitamin products remain the entry point for many consumers. Category development increasingly depends on combining familiar nutrients with specific lifestyle needs, including immunity, beauty, energy, and convenience-oriented daily regimens.

Probiotics

Probiotic gummies are projected to reach USD 7.0 billion by 2035 and advance at a 9.5% CAGR (2026-2035). The segment addresses consumer interest in digestive health but requires careful control of ingredient viability, dosage, and shelf stability. Suppliers that can substantiate these attributes without sacrificing taste have a more credible route to premium positioning.

Collagen

Collagen gummies generated USD 2.0 billion in 2025 and are forecast to grow at an 11.6% CAGR (2026-2035). Beauty-from-within positioning supports demand across skin, hair, and joint-health occasions. The category is commercially attractive because it links wellness claims with lifestyle branding and visual discovery channels, although ingredient sourcing and product credibility remain important differentiators.

Melatonin

Melatonin gummies are projected to reach USD 3.2 billion by 2035 and expand at an 8.8% CAGR (2026-2035). Sleep-support products have become a mainstream gummy occasion, but they also face heightened scrutiny around dosage communication and child access. Brands must balance convenience and approachable branding with responsible packaging and clear consumer guidance.

CBD

CBD gummies generated USD 700 million in 2025 and are forecast to grow at a 10.7% CAGR (2026-2035). The category's potential is linked to the evolution of national cannabinoid rules and the ability of manufacturers to navigate inconsistent approval requirements. Regulatory clarity, product testing, and channel acceptance will determine whether CBD formats achieve broader international scale.

By Formulation Base

Gelatin

Gelatin-based gummies are projected to reach USD 54.7 billion by 2035 and grow at a 7.0% CAGR (2026-2035). Gelatin retains advantages in texture, processing familiarity, and established manufacturing infrastructure. Its comparatively slower expansion reflects increasing consumer interest in plant-based alternatives and the need for manufacturers to address ingredient-origin constraints across diverse consumer groups.

Pectin

Pectin-based gummies generated USD 7.1 billion in 2025 and are forecast to advance at a 13.4% CAGR (2026-2035). Pectin is strategically important because it supports vegan, halal-eligible, and clean-label product positioning. Its uptake is strongest where brands are reformulating supplement and functional-food portfolios to widen demographic relevance and improve alignment with lifestyle-led purchasing criteria.

Starch

Starch-based gummies generated USD 3.2 billion in 2025 and are expected to reach USD 7.3 billion by 2035. Starch offers a plant-based option that can be attractive in cost-sensitive confectionery and supplement applications. Its role is likely to remain strongest where manufacturers need a balance between accessible pricing, formulation flexibility, and non-gelatin positioning.

By End User

Adults (18-59)

Adults aged 18-59 generated USD 22.3 billion in 2025 and are projected to account for USD 47.4 billion by 2035. Adults represent the broadest consumer base because they purchase across confectionery, supplement, functional-food, and OTC occasions. Their behavior also underpins the growth of digital discovery, subscription replenishment, and targeted wellness categories such as beauty, stress, sleep, and immunity.

Children (2-17)

Children aged 2-17 generated USD 11.0 billion in 2025 and are forecast to grow at a 7.7% CAGR (2026-2035). Children remain central to confectionery and pediatric supplementation, but product design is shaped by parental expectations around sugar, colors, daily dosage, and safety. This creates a commercial advantage for brands that can pair child-friendly delivery with responsible packaging and clearly controlled formulations.

Geriatric (60+)

Geriatric consumers aged 60+ are projected to reach USD 21.0 billion by 2035 and expand at a 12.6% CAGR (2026-2035). Older consumers represent a high-value growth opportunity because ease of consumption can be especially relevant for regular supplement and OTC use. Products designed around bone health, joint support, cognition, and general wellness must still meet the higher expectations for credibility, accessibility, and dosage clarity common in this cohort.

By Distribution Channel

Offline

Offline channels generated USD 26.2 billion in 2025 and are projected to reach USD 50.3 billion by 2035. Pharmacies, grocery stores, mass merchants, specialty retailers, and convenience outlets remain essential for high-volume confectionery and established supplement brands. Physical presence also supports immediate purchase, retailer trust, and consumer discovery in categories where health positioning benefits from familiar channels.

Online

Online channels generated USD 13.0 billion in 2025 and are expected to reach USD 40.9 billion by 2035. Digital channels are reshaping the route to market for specialized gummy brands by supporting direct consumer education, recurring orders, and faster testing of niche wellness concepts. The channel favors suppliers that can manage digital acquisition costs, subscription retention, and compliant health communication.

Gummy Market Regional Analysis

North America Gummy Market Analysis

The gummy market in North America generated USD 14.9 billion in 2025 and is projected to reach USD 32.5 billion by 2035. The region combines mature confectionery demand with a highly developed supplement ecosystem, extensive pharmacy and mass-retail coverage, and established digital wellness purchasing. Its commercial depth makes it an important proving ground for new formats, premium active ingredients, and differentiated brand propositions.

U.S.

The U.S. gummy market generated USD 12.7 billion in 2025 and is forecast to grow at an 8.0% CAGR (2026-2035). The country's combination of large-scale confectionery consumption, broad supplement adoption, and sophisticated e-commerce distribution supports a diverse competitive base. Private-label activity remains significant, increasing the importance of formulation distinction and brand credibility.

Canada

Canada generated USD 2.2 billion in 2025 and is expected to grow at an 8.2% CAGR (2026-2035). The market benefits from close integration with U.S. consumer brands and retail systems while retaining a distinct natural-health-product compliance environment. Established domestic supplement brands and pharmacy-oriented channels support demand for credible wellness products.

Europe Gummy Market Analysis

Europe is projected to reach USD 23.1 billion by 2035, from USD 10.8 billion in 2025. Europe combines the historic center of gummy confectionery with a growing market for health-oriented formats. Cross-market expansion requires careful management of country-level retail structures, consumer preferences, and regulatory requirements for supplements and functional ingredients.

Germany

Germany generated USD 2.4 billion in 2025 and is forecast to grow at a 7.1% CAGR (2026-2035). Germany remains a core confectionery innovation market while also supporting incremental supplement-gummy adoption. Product credibility, pharmacy-channel dynamics, and established candy preferences create a distinctive market balance between traditional and health-oriented formats.

UK

The UK market is projected to reach USD 4.0 billion by 2035 and advance at an 8.0% CAGR (2026-2035). The country has become an important market for digitally marketed wellness gummies and pharmacy-distributed consumer-health brands. Its commercial environment supports faster testing of targeted formulations, although suppliers must maintain clear product claims and regulatory discipline.

France

France generated USD 1.3 billion in 2025 and is projected to reach USD 2.7 billion by 2035. Demand is supported by growing lifestyle-health interest, particularly for products with natural and clean-label credentials. Pharmacy traditions remain influential, making trust, quality signaling, and premium positioning important for supplement-gummy suppliers.

Italy

Italy remains a developing European market in which confectionery consumption is more established than supplement-gummy penetration. Health-and-wellness retail growth creates an opportunity for brands able to navigate fragmented distribution and local consumer preferences.

Spain

Spain combines a meaningful confectionery base with an earlier-stage supplement-gummy opportunity. Expansion will depend on improving health-product visibility across pharmacy, specialty retail, and digital channels.

Rest of Europe

Rest of Europe includes markets where rising health awareness and expanding e-commerce are broadening access to supplement gummies. Localized compliance, pricing, and channel strategies remain necessary because consumer behavior varies substantially across the region.

Asia Pacific Gummy Market Analysis

The gummy market in Asia Pacific generated USD 8.6 billion in 2025 and is forecast to grow at a 9.6% CAGR (2026-2035). The region encompasses developed functional-food markets alongside large populations of newer supplement buyers. This diversity makes local formulation preferences, regulatory pathways, online platforms, and consumer-health positioning more important than a single regional go-to-market strategy.

China

China generated USD 3.6 billion in 2025 and is projected to reach USD 9.8 billion by 2035. China is the region's largest gummy market, supported by urban consumer demand, growing wellness expenditure, and domestic manufacturing capabilities. Suppliers need to align product registration, cross-border or domestic channel strategy, and local digital-commerce execution.

Japan

Japan generated USD 1.5 billion in 2025 and is forecast to expand at a 7.6% CAGR (2026-2035). The market benefits from sophisticated functional-food consumption and a strong consumer interest in targeted wellness and beauty formats. High expectations for quality, texture, and product specificity favor manufacturers with deep formulation and brand-development capabilities.

India

India is projected to reach USD 3.8 billion by 2035 and grow at a 12.7% CAGR (2026-2035). India's opportunity reflects rising urban health awareness and a comparatively low base for gummy supplementation. E-commerce is particularly important in extending premium and specialized products beyond major metropolitan retail networks.

South Korea

South Korea generated USD 600 million in 2025 and is expected to reach USD 1.4 billion by 2035. Beauty and wellness culture, strong online purchasing behavior, and consumer familiarity with health-function products underpin demand. Collagen and appearance-led supplement positioning are particularly relevant to the market's product-development landscape.

Australia

Australia is a mature supplement-gummy market with established pharmacy distribution and high consumer familiarity with wellness products. Its commercial profile favors trusted brands and differentiated products rather than rapid expansion from a low penetration base.

Rest of Asia Pacific

Rest of Asia Pacific presents an early-stage opportunity shaped by increasing digital access, middle-class health spending, and the ability of gummy formats to establish new consumer habits. Local partnerships and price architecture will be important in converting regional interest into sustained demand.

Latin America Gummy Market Analysis

The gummy market in Latin America generated USD 2.8 billion in 2025 and is forecast to grow at an 11.4% CAGR (2026-2035). Regional demand is supported by expanding health-and-wellness expenditure, pharmacy-chain development, and e-commerce adoption. Confectionery remains material, but supplement gummies are increasingly defining the market's growth profile among urban consumers.

Brazil

Brazil generated USD 1.6 billion in 2025 and is projected to reach USD 4.4 billion by 2035. Brazil is the region's largest national market, with a substantial consumer base and growing local manufacturing and supplement-brand activity. Regulatory familiarity and products adapted to local consumer preferences can provide domestic suppliers with a meaningful competitive advantage.

Mexico

Mexico generated USD 800 million in 2025 and is forecast to expand at a 10.4% CAGR (2026-2035). The market combines a large confectionery consumer base with growing demand for accessible wellness products. Pharmacy growth and online retail are important pathways for specialized supplement gummies seeking broader national reach.

Rest of Latin America

Rest of Latin America includes markets at varying stages of supplement adoption and retail infrastructure development. The strongest opportunities are likely to emerge where digital commerce and consumer-health spending advance together.

Middle East & Africa Gummy Market Analysis

The gummy market in Middle East & Africa is projected to reach USD 5.5 billion by 2035 and grow at a 10.2% CAGR (2026-2035). Growth is supported by rising health expenditure, increasingly modern pharmacy and retail systems, and demand for formulations aligned with halal requirements. Ingredient sourcing and certification are central commercial considerations rather than secondary product attributes.

Saudi Arabia

Saudi Arabia generated USD 700 million in 2025 and is projected to reach USD 1.9 billion by 2035. The market benefits from preventive-health interest, retail modernization, and a young consumer population. Halal-compliant formulations can be a key market-access requirement, supporting the strategic relevance of plant-based gelling systems and transparent ingredient controls.

UAE

The UAE generated USD 400 million in 2025 and is forecast to grow at a 10.7% CAGR (2026-2035). The country functions as an important regional distribution and consumer-health hub, supported by advanced retail, pharmacy, and e-commerce networks. Its diverse consumer base supports demand for premium imported and internationally positioned wellness brands.

South Africa

South Africa has relatively developed supplement retail infrastructure compared with many Sub-Saharan markets, but affordability and import-cost pressures can limit premium gummy penetration. Brands must balance wellness positioning with price accessibility and channel-specific assortment strategies.

Rest of MEA

Rest of MEA represents a varied set of early-stage markets where digital access and consumer-health awareness are widening the opportunity for supplement gummies. Distribution capability, certification, and localized affordability will shape the pace of market development.

Gummy Market Share & Competitive Landscape

The gummy market share structure is fragmented, with the five largest companies collectively accounting for approximately 13.8% combined revenue share in 2025. Competition varies materially by application: confectionery relies on brand familiarity and retail breadth, while supplements and pharmaceutical gummies place greater weight on formulation quality, regulatory competence, clinical credibility, and channel specialization.

Haribo GmbH & Co. KG held a 5.0% market share in 2025.

Haribo's position is rooted in global confectionery distribution, established brand recognition, and continuing investment in flavor and texture-led innovation. Its strength in mass-market gummies gives the company scale advantages in manufacturing and retail execution, even as functional and health-oriented formats reshape the wider market's value mix.

Ferrara Candy Company / Trolli held a 4.7% market share in 2025.

Ferrara's competitive strength is concentrated in North American confectionery, where distinctive formats and high-visibility retail brands support consumer engagement. The company illustrates how product novelty and recognizable sensory experiences can sustain relevance in a mature candy environment.

Haleon plc, including Centrum Gummies, held a 1.5% market share in 2025.

Haleon competes from a consumer-health position, leveraging pharmacy relationships and trusted multivitamin branding. Its challenge and opportunity lie in extending that trust into targeted gummy occasions while maintaining the quality and substantiation expectations associated with established health brands.

Church & Dwight, Bayer, Pharmavite, Unilever, H&H Group, Jamieson Wellness, Meiji, Procaps, Perfetti Van Melle, Cloetta, Piping Rock Health Products, Sirio Pharma, Goli Nutrition, MaryRuth Organics, Herbaland Naturals, and Vitajoy Group participate through differing combinations of branded supplements, confectionery, pharmaceutical development, and contract manufacturing. The breadth of participants reinforces the market's low concentration while increasing pressure on suppliers to distinguish themselves through product quality, active-ingredient expertise, manufacturing capability, and channel reach.

Recent Industry Developments

Unilever announced an agreement to acquire functional gummy brand Grüns in April 2026, extending its wellbeing portfolio further into food-based supplement positioning ^{[4]Reuters. “Unilever to buy supplements brand Grüns, boosting wellbeing focus post food spin-off.” reuters.com}.

TopGum completed its acquisition of PL Developments' U.S. gummy manufacturing operations in May 2026, adding pharmaceutical-oriented manufacturing capability and expanding its North American platform ^{[5]PR Newswire (TopGum Industries Ltd.). “TopGum Completes U.S. Acquisition of PL Developments Valued at Up to USD 35 Million.” prnewswire.com}.

HARIBO introduced Balla Bites and Balla Bites Sour in August 2026, expanding its portfolio with a multi-texture gummy format made without artificial colors ^{[6]PR Newswire (HARIBO of America). “HARIBO Introduces Balla Bites & Balla Bites Sour.” prnewswire.com}.

Vitafusion introduced Vital NMN Gummies during 2026, positioning the product around healthy-aging and cellular-health consumer interest ^{[7]PR Newswire (Vitafusion / Piping Rock Health Products). “Vitafusion Says 'Aging? Love It.' with Launch of Vital NMN Gummies.” prnewswire.com}.